NFKB1 and neoplasm: Under normal conditions, LPS activates the NF-κB signaling pathway in immune cells such as macrophages and dendritic cells (DCs), stimulating their secretion of pro-inflammatory cytokines and immunomodulatory factors to promote anti-tumor immune responses (20).